摘要
目的:研究血浆中CD63水平的变化在2型糖尿病中的临床意义。方法:采用流式细胞仪分别检测54名健康人(NC组),55例2型糖尿病患者(T2DM组)的血浆血小板活化标志物(CD63)水平。结果:2型糖尿病患者血小板因子CD63异常升高,NC组与T2DM组的血浆血小板活化标志物CD63水平相比,有显著性差异(P<0.01)。结论:血小板因子CD63的检测可以作为2型糖尿病患者早期诊断和病情监测的一个临床指标。
Objective:To study the level of CD63 in plasma in patients with T2DM and its clinical significance.Methods:Level of CD63 in plasma was detected by flowcytometer in 55 patients with T2DM(T2DM group)and 54 healthy Subjects(NC group).Results:Level of CD63 in plasma in T2DM group(13.53±0.66)was significantly higher than that in NC group(8.49±0.27)(P0.01).Conclusion:Level of CD63 in plasma in patients with T2DM is significantly higher than that in normal control group.So the level of CD63 in plasma can be a clinical sign for T2DM patients to early discovery and condition monitor.
出处
《河南大学学报(医学版)》
CAS
2011年第1期58-59,共2页
Journal of Henan University:Medical Science
基金
河南省科技攻关基金资助项目(0424410102)